Citable company snapshot
IDEXX LABORATORIES INC /DE's latest SEC-sourced 2026-06-30 period shows $1.22B in revenue and $338.41M in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| Revenue | Jun 30, 2026 | $1.22B | $1.14B | +6.6% |
| Gross Profit | Jun 30, 2026 | $779.09M | $722.74M | +7.8% |
| Operating Income | Jun 30, 2026 | $425.57M | $362.59M | +17.4% |
| Net Income | Jun 30, 2026 | $338.41M | $278.45M | +21.5% |
| Operating Cash Flow (computed) | Jun 30, 2026 | $347.16M | $266.25M | +30.4% |
| Free Cash Flow (computed) | Jun 30, 2026 | $322.52M | $234.26M | +37.7% |
Source: SEC EDGAR financial statements; period Jun 30, 2026; filed Aug 4, 2026; accession 0000874716-26-000123.
IDXX company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.